| | **** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS **** 
 +----------------+--------------------------------------+----------+-----------+
 |      CAS#      |              Chemical Name           |    %     |  EINECS#  |
 |----------------|--------------------------------------|----------|-----------|
 |     1670-14-0  |Benzamidine hydrochloride             |   99.0   | 216-795-4 |
 +----------------+--------------------------------------+----------+-----------+
 Hazard Symbols: XI
 Risk Phrases: 36/37/38
 
 **** SECTION 3 - HAZARDS IDENTIFICATION ****
 
 EMERGENCY OVERVIEW
 Irritating to eyes, respiratory system and skin.The toxicological
 properties of this material have not been fully
 investigated.Moisture sensitive.Hygroscopic (absorbs moisture from
 the air).
 
 Potential Health Effects
 Eye:
 Causes eye irritation.  May cause chemical conjunctivitis.
 Skin:
 Causes skin irritation.
 Ingestion:
 May cause gastrointestinal irritation with nausea, vomiting and
 diarrhea. The toxicological properties of this substance have not
 been fully investigated.
 Inhalation:
 Causes respiratory tract irritation. The toxicological properties of
 this substance have not been fully investigated. Can produce delayed
 pulmonary edema.
 Chronic:
 Effects may be delayed.
 
 **** SECTION 4 - FIRST AID MEASURES ****
 
 Eyes:
 Immediately flush eyes with plenty of water for at least 15 minutes,
 occasionally lifting the upper and lower eyelids. Get medical aid.
 Skin:
 Get medical aid. Flush skin with plenty of water for at least 15
 minutes while removing contaminated clothing and shoes. Wash clothing
 before reuse.
 Ingestion:
 If victim is conscious and alert, give 2-4 cupfuls of milk or water.
 Never give anything by mouth to an unconscious person. Get medical
 aid. Get medical aid immediately. Do NOT induce vomiting. If
 conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or
 water.
 Inhalation:
 Remove from exposure and move to fresh air immediately. If not
 breathing, give artificial respiration. If breathing is difficult,
 give oxygen. Get medical aid.
 Notes to Physician:
 Treat symptomatically and supportively.
 
 **** SECTION 5 - FIRE FIGHTING MEASURES ****
 
 General Information:
 As in any fire, wear a self-contained breathing apparatus in
 pressure-demand, MSHA/NIOSH (approved or equivalent), and full
 protective gear. Dusts at sufficient concentrations can form
 explosive mixtures with air. Combustion generates toxic fumes. During
 a fire, irritating and highly toxic gases may be generated by thermal
 decomposition or combustion.
 Extinguishing Media:
 For small fires, use water spray, dry chemical, carbon dioxide or
 chemical foam. Use water spray, dry chemical, carbon dioxide, or
 appropriate foam.
 
 **** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
 
 General Information: Use proper personal protective equipment as indicated
 in Section 8.
 Spills/Leaks:
 Clean up spills immediately, observing precautions in the Protective
 Equipment section. Sweep up, then place into a suitable container for
 disposal. Sweep up or absorb material, then place into a suitable
 clean, dry, closed container for disposal. Avoid generating dusty
 conditions. Provide ventilation.
 
 **** SECTION 7 - HANDLING and STORAGE ****
 
 Handling:
 Wash thoroughly after handling. Use with adequate ventilation.
 Minimize dust generation and accumulation. Avoid contact with eyes,
 skin, and clothing. Avoid contact with skin and eyes. Keep container
 tightly closed. Avoid ingestion and inhalation. Use with adequate
 ventilation. Wash clothing before reuse.
 Storage:
 Store in a tightly closed container. Store in a cool, dry,
 well-ventilated area away from incompatible substances. Store
 protected from moisture.
 
 **** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
 
 Engineering Controls:
 Facilities storing or utilizing this material should be equipped
 with an eyewash facility and a safety shower. Use adequate
 ventilation to keep airborne concentrations low.
 Exposure Limits
 CAS# 1670-14-0:
 
 
 Personal Protective Equipment
 
 Eyes:
 Wear appropriate protective eyeglasses or chemical
 safety goggles as described by OSHA's eye and face
 protection regulations in 29 CFR 1910.133 or European
 Standard EN166.
 Skin:
 Wear appropriate protective gloves to prevent skin
 exposure.
 Clothing:
 Wear appropriate protective clothing to prevent skin
 exposure.
 Respirators:
 A respiratory protection program that meets OSHA's 29
 CFR 1910.134 and ANSI Z88.2 requirements or European
 Standard EN 149 must be followed whenever workplace
 conditions warrant respirator use. Follow the OSHA
 respirator regulations found in 29 CFR 1910.134 or
 European Standard EN 149. Use a NIOSH/MSHA or
 European Standard EN 149 approved respirator if
 exposure limits are exceeded or if irritation or
 other symptoms are experienced.
 
 **** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
 
 Physical State:             Solid
 Color:                      white to off-white
 Odor:                       None reported.
 pH:                         Not available.
 Vapor Pressure:             Negligible.
 Viscosity:                  Not available.
 Boiling Point:              Not available.
 Freezing/Melting Point:     77 deg C
 Autoignition Temperature:   Not available.
 Flash Point:                Not available.
 Explosion Limits, lower:    Not available.
 Explosion Limits, upper:    Not available.
 Decomposition Temperature:
 Solubility in water:
 Specific Gravity/Density:
 Molecular Formula:          C7H8N2.HCl
 Molecular Weight:           156.61
 
 **** SECTION 10 - STABILITY AND REACTIVITY ****
 
 Chemical Stability:
 Stable at room temperature in closed containers under normal storage
 and handling conditions.
 Conditions to Avoid:
 High temperatures, incompatible materials, excess heat, exposure to
 moist air or water.
 Incompatibilities with Other Materials:
 Moisture.
 Hazardous Decomposition Products:
 Hydrogen chloride, nitrogen oxides, carbon monoxide, carbon dioxide.
 Hazardous Polymerization: Has not been reported.
 
 **** SECTION 11 - TOXICOLOGICAL INFORMATION ****
 
 RTECS#:
 CAS# 1670-14-0: CV6260000
 LD50/LC50:
 Not available.
 Carcinogenicity:
 Benzamidine hydrochloride -
 Not listed by ACGIH, IARC, or NTP.
 Other:
 See actual entry in RTECS for complete information.
 
 **** SECTION 12 - ECOLOGICAL INFORMATION ****
 
 
 
 **** SECTION 13 - DISPOSAL CONSIDERATIONS ****
 
 Dispose of in a manner consistent with federal, state, and local regulations.
 
 **** SECTION 14 - TRANSPORT INFORMATION ****
 
 IATA
 Not regulated as a hazardous material.
 IMO
 Not regulated as a hazardous material.
 RID/ADR
 Not regulated as a hazardous material.
 
 **** SECTION 15 - REGULATORY INFORMATION ****
 
 European/International Regulations
 European Labeling in Accordance with EC Directives
 Hazard Symbols: XI
 Risk Phrases:
 R 36/37/38  Irritating to eyes, respiratory system
 and skin.
 Safety Phrases:
 S 24/25  Avoid contact with skin and eyes.
 WGK (Water Danger/Protection)
 CAS# 1670-14-0: No information available.
 Canada
 CAS# 1670-14-0 is listed on Canada's DSL List.
 CAS# 1670-14-0 is not listed on Canada's Ingredient Disclosure List.
 US FEDERAL
 TSCA
 CAS# 1670-14-0 is listed on the TSCA inventory.
 
 **** SECTION 16 - ADDITIONAL INFORMATION ****
 
 MSDS Creation Date:  9/02/1997  Revision #6 Date:  3/18/2003
 
 The information above is believed to be accurate and represents the best
 information currently available to us. However, we make no warranty of
 merchantability or any other warranty, express or implied, with respect to
 such information, and we assume no liability resulting from its use. Users
 should make their own investigations to determine the suitability of the
 information for their particular purposes. In no way shall the company be
 liable for any claims, losses, or damages of any third party or for lost
 profits or any special, indirect, incidental, consequential or exemplary
 damages, howsoever arising, even if the company has been advised of
 the possibility of such damages.
 --------------------------------------------------------------------------------
 --------------------------------------------------------------------------------
 
 |  | 
 | 
| 
| ALL MSDS PAGES IN THIS GROUP |  | | NAME | CAS |  
| 5-Formyl-2-furansulfonic acid, sodium salt, 98% | 31795-44-5 |  
| 1,10-Phenanthroline monohydrate, reagent ACS | 66-71-7 |  
| Phenol Red Sodium Salt, Reagent ACS | 34487-61-1 |  
| Phloxine B | 18472-87-2 |  
| (1-Aminohexyl)phosphonic acid, 97% | 63207-60-3 |  
| Pyruvic acid, sodium salt, 99+% | 113-24-6 |  
| (1-Amino-2-methylpropyl)phosponic acid, 97% | 18108-24-2 |  
| Rose bengal (cert) | 632-69-9 |  
| Safranin O certified | 477-73-6 |  
| (1-Amino-3-Methylbutyl)Phosphonic Acid, 97% | 20459-60-3 |  
| Diethyldithiocarbamic acid, sodium salt, trihydrate | 148-18-5 |  
| Sudan iii  (cert) | 85-86-9 |  
| Sudan IV  (Cert), 95% (UV-VIS) | 85-83-6 |  
| Sudan Black B (Cert), 99%  (UV-VIS) | 4197-25-5 |  
| Thenoyltrifluoroacetone, 99% | 326-91-0 |  
| Thionin (Cert) | 581-64-6 |  
| (1-Amino-2-methylbutyl)phosphonic acid, 97% | 20459-61-4 |  
| Toluidine Blue O (Cert) | 92-31-9 |  
| (1-Aminooctyl)phosphonic acid, 97% | 94219-58-6 |  
| tris-(Hydroxymethyl)-aminomethane  hydrochloride, 99+% | 1185-53-1 |  
| Brilliant Blue G | 6104-58-1 |  
| Ethidium Bromide, 95% | 1239-45-8 |  
| Ponceau S | 6226-79-5 |  
| Pyronin Y, certified | 92-32-0 |  
| Nitro BT, 85% (Titr.) | 298-83-9 |  
| (r,r)-Dithiothreitol, 98% (titr.) | 3483-12-3 |  
| Dithioerythritol, 95% (Titr.) | 6892-68-8 |  
| Guanidine Thiocyanate, 99% (Titr.) | 593-84-0 |  
| D(+)-Biotin, 98% | 58-85-5 |  
| 2-(4-Morpholino)ethanesulfonic Acid, 99% (titr.) | 4432-31-9 |  
| Diethylmethylphosphonate, 96% | 683-08-9 |  
| 2,2-Bis(Hydroxymethyl)-2,2',2"-Nitrilo- Triethanol, 99+% | 6976-37-0 |  
| ACES, 96% | 7365-82-4 |  
| HEPES, 99% | 7365-45-9 |  
| Tricine, 98+% | 5704-04-1 |  
| Caps (3-Cyclohexylamino-1-Propanesulfonic  Acid), 99% | 1135-40-6 |  
| 4'-Bromoacetanilide, 98% | 103-88-8 |  
| l-Isoleucine, 99% | 73-32-5 |  
| l-Leucine, 99% | 61-90-5 |  
| L-(+)-Ornithine-Hydrochloride, 99% | 3184-13-2 |  
| l-Threonine, 98% | 72-19-5 |  
| Benzamidine hydrochloride, 99% (titr.) | 1670-14-0 |  
| 2,3-Dihydrofuran, 98% | 1191-99-7 |  
| Ches 98+% | 103-47-9 |  
| FMOC-L-Asparagin Acid-Beta-T-Butylester, 98% | 71989-14-5 |  
| 2-Chloropyridine, 99% | 109-09-1 |  
| N,N'-Diisopropylcarbodiimide, 99% | 693-13-0 |  
| N,N-Diisopropylethylamine | 7087-68-5 |  
| 4-Dimethylaminopyridine, 99% | 1122-58-3 |  
| D-Pantothenic Acid Calcium Salt, 97.5-102.0% (from Calcium Content,on | 137-08-6 | 
 | 
 |